Arcutis Biotherapeutics(ARQT) - 2022 Q3 - Earnings Call Transcript
Arcutis Biotherapeutics(ARQT)2022-11-14 15:36
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Q3 2022 Earnings Conference Call November 8, 2022 5:00 PM ET Company Participants Eric McIntyre - Head, IR Todd Watanabe - President, CEO & Director Kenneth Lock - Chief Commercial Officer Patrick Burnett - SVP & Chief Medical Officer Scott Burrows - CFO & Principal Accounting Officer Conference Call Participants Kenneth Cacciatore - Cowen Vikram Purohit - Morgan Stanley Louise Chen - Cantor Fitzgerald Serge Belanger - Needham & Company Seamus Fernandez - Guggenhe ...